Vasculitis resulting from a superficial femoral artery angioplasty with a paclitaxel-eluting balloon

Journal of Vascular Surgery

Volumn 59, Issue 2, 2014, Pages 520-523

  Thomas, Shannon D ^a   McDonald, Robert R A ^b,c   Varcoe, Ramon L ^a,d  

^a PRINCE OF WALES HOSPITAL   (Australia)

^b Blue Sky Green Consulting   (Australia)

^c ST VINCENT S HOSPITAL   (Australia)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PACLITAXEL;

AGED; ANGIOGRAPHY; ANGIOPLASTY; ARTICLE; BALLOON; BALLOON CATHETER; CASE REPORT; CATHETER SHEATH; CLAUDICATION; DRUG ELUTING BALLOON; EDEMA; FEMALE; FEMORAL ARTERY; FOLLOW UP; HUMAN; PRIORITY JOURNAL; PUNCH BIOPSY; STEROID THERAPY; VASCULITIS;

AGED; ANGIOPLASTY, BALLOON; BIOPSY; CARDIOVASCULAR AGENTS; COATED MATERIALS, BIOCOMPATIBLE; FEMALE; FEMORAL ARTERY; HUMANS; INTERMITTENT CLAUDICATION; PACLITAXEL; TREATMENT OUTCOME; VASCULAR ACCESS DEVICES; VASCULAR PATENCY; VASCULITIS;

EID: 84892922476     PISSN: 07415214     EISSN: 10976809     Source Type: Journal    
DOI: 10.1016/j.jvs.2013.03.013     Document Type: Article

References (19)

1. A. Schmidt, M. Piorkowski, M. Werner, M. Ulrich, Y. Bausback, and S. Bräunlich et al. First experience with drug-eluting balloons in infrapopliteal arteries: restenosis rate and clinical outcome J Am Coll Cardiol 58 2011 1105 1109
2. G. Tepe, T. Zeller, T. Albrecht, S. Heller, U. Schwarzwälder, and J.P. Beregi et al. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg N Engl J Med 358 2008 689 699
3. M. Werk, S. Langner, B. Reinkensmeier, H.F. Boettcher, G. Tepe, and U. Dietz et al. Inhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial Circulation 118 2008 1358 1365
4. K. Katsanos, D. Karnabatidis, P. Kitrou, S. Spiliopoulos, N. Christeas, and D. Siablis Paclitaxel-coated balloon angioplasty vs. plain balloon dilation for the treatment of failing dialysis access: 6-month interim results from a prospective randomized controlled trial J Endovasc Ther 19 2012 263 272
5. B. Cortese, A. Micheli, A. Picchi, A. Coppolaro, L. Bandinelli, and S. Severi et al. Paclitaxel-coated balloon versus drug-eluting stent during PCI of small coronary vessels, a prospective randomised clinical trial. The PICCOLETO study Heart 96 2010 1291 1296
6. F. Liistro, I. Porto, S. Grotti, G. Ventoruzzo, R. Vergallo, and G. Bellandi et al. Drug-eluting balloon angioplasty for carotid in-stent restenosis J Endovasc Ther 19 2012 729 733
7. P. Montorsi, S. Galli, P.M. Ravagnani, D. Rabattoni, F. Fabbiocchi, and A. Lualdi et al. Drug-eluting balloon for treatment of in-stent restenosis after carotid artery stenting: preliminary report J Endovasc Ther 19 2012 734 742
8. J.P. Loh, and R. Waksman Paclitaxel drug-coated balloons: a review of current status and emerging applications in native coronary artery de novo lesions JACC Cardiovasc Interv 5 2012 1001 1012
9. A.C. Newby, and A.B. Zaltsman Molecular mechanisms in intimal hyperplasia J Pathol 190 2000 300 309
10. B. Scheller, C. Hehrlein, W. Bocksch, W. Rutsch, D. Haghi, and U. Dietz et al. Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter N Engl J Med 355 2006 2113 2124
11. T. Heilmann, C. Richter, H. Noack, S. Post, D. Mahnkopf, and H. Figulla Drug release profiles of different drug-coated balloon platforms Eur Cardiol 6 2010 40 44
12. P. Freyhardt, T. Zeller, T.J. Kröncke, U. Schwarzwaelder, N.F. Schreiter, and H. Stiepani et al. Plasma levels following application of paclitaxel-coated balloon catheters in patients with stenotic or occluded femoropopliteal arteries Rofo 183 2011 448 455
13. B. Scheller, U. Speck, C. Abramjuk, U. Bernhardt, M. Bohm, and G. Nickenig Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis Circulation 110 2004 810 814
14. D.S. Dizon, J. Schwartz, A. Rojan, J. Miller, L. Pires, and P. Disilvestro et al. Cross-sensitivity between paclitaxel and docetaxel in a women's cancers program Gynecol Oncol 100 2006 149 151
15. D.G. Bukacel, R. Bander, and R.B. Ibrahim Cross-reactivity between paclitaxel and hazelnut: a case report J Oncol Pharm Pract 13 2007 53 55
16. R. Beri, F.R. Rosen, M.J. Pacini, and S.R. Desai Severe dermatologic reactions at multiple sites after paclitaxel administration Ann Pharmacother 38 2004 238 241
17. Y. Kataoka, S.R. Kapadia, R. Puri, J.E. Harvey, J. Martin, and S.J. Nicholls et al. Suspected hypersensitivity reaction following drug-eluting stent implantation. Novel insights with optical coherence tomography JACC Cardiovasc Interv 5 2012 e21 e23
18. J.R. Nebeker, R. Virmani, C.L. Bennett, J.M. Hoffman, M.H. Samore, and J. Alvarez et al. Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project J Am Coll Cardiol 47 2006 175 181
19. R. Waksman, and R. Pakala Drug-eluting balloon: the comeback kid? Circulation Cardiovasc Interv 2 2009 352 358